Align Technology | ALGN - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
3M USD 878M 119M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cardinal Health USD 630M 32M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cooper Companies USD 192.2M 75.4M 2025-12
CVS Health USD 3.94B 2.58B 2026-03
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Henry Schein USD 150M 17M 2026-03
Idexx Laboratories USD 355.44M 48.46M 2026-03
Insulet USD 113M 27.2M 2026-03
Integra LifeSciences USD -2.41M 6.72M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
McKesson USD 1.63B 235M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Solventum Corp USD 332M 179M 2025-12
Stryker USD 1.7B 676M 2025-12
Teleflex USD 218.94M 657.52M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veeva Systems USD 469.79M 152.26M 2026-03
Waters USD 264.18M 94.06M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12
Zoetis USD 761M 126M 2025-12